Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deep Brain Innovations LLC

Latest From Deep Brain Innovations LLC

Deep Brain Stimulation Probes New Frontiers

Deep brain stimulation (DBS) currently comprises only about a quarter of the worldwide neuromodulation device market, but growth in this segment is strong. Both large and small competitors have targeted DBS, which has the potential to address a number of highly prevalent and underserved diseases and disorders.

Medical Device

Out Of The Blocks, June 2013

Brief profiles of these recently formed companies: AntiOp, Deep Brain Innovations, Eco Neurologics Inc., eFFECTOR Therapeutics, ElsaLys Biotech, Synfolia, and Trino Therapeutics.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Deep Brain Innovations LLC
  • Senior Management
  • Geoffrey B Thrope, CEO
    Marilyn Eisele, VP, Fin. & CFO
    Warren Grill, PhD, CSO
  • Contact Info
  • Deep Brain Innovations LLC
    Phone: (216) 378-9106
    22901 Milcreek Blvd.
    Cleveland, OH 44122